tiprankstipranks
Trending News
More News >
Akebia Therapeutics (AKBA)
NASDAQ:AKBA

Akebia Therapeutics (AKBA) Revenue

Compare
1,418 Followers

Akebia Therapeutics Revenue

Akebia Therapeutics had a revenue of 46.50M in the quarter ending Dec 31, 2024, with 24.23%. This bring the company's revenue in the last twelve months to 160.18M, Increased -5.71%. In the fiscal year ending Dec 31, 2024, Akebia Therapeutics had annual revenue of 160.18M with -17.70% growth.
Revenue (ttm)
160.18M
Revenue Growth
-17.75%
P/S Ratio
4.28
Revenue/Employee
$884,972
Employees
181
Market Cap
$685.48M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
160.18M-34.44M-17.70%
Dec 31, 2023
194.62M-97.98M-33.49%
Dec 31, 2022
292.60M79.02M+37.00%
Dec 31, 2021
213.58M-81.73M-27.68%
Dec 31, 2020
295.31M-39.69M-11.85%
Dec 31, 2019
335.00M127.26M+61.26%
Dec 31, 2018
207.74M29.76M+16.72%
Dec 31, 2017
177.98M176.45M+11,495.05%
Dec 31, 2016
1.53M+∞%
Dec 31, 2015
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis